Q-omics provides the consensus-scored RNU4-63P profile across patient tissues and cancer cell-line models. RNU4-63P expression is associated with patient survival in 4 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, RNU4-63P RNA expression shows 5,594 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where RNU4-63P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.